Consumer Goods » Food, Beverages & Tobacco | Mera Pharmaceuticals Inc.

Mera Pharmaceuticals Inc. | Income Statement

Fiscal year is November-October. All values USD Thousands.
2006
2007
2008
2009
2010
Sales/Revenue
386.80
470.40
610.00
599.10
288.90
Cost of Goods Sold (COGS) incl. D&A
-
-
259.80
112.70
74.10
Gross Income
92.20
198.40
350.10
486.40
214.80
SG&A Expense
-
-
644.20
688.30
452.10
Unusual Expense
-
-
1,684.70
20.40
314.40
Non Operating Income/Expense
2.20
-
11.20
0.70
0.40
Interest Expense
-
-
10.10
5.00
5.00
Pretax Income
520.80
338.80
1,977.10
224.10
557.10
Income Tax
12.40
16.60
31.70
31.20
19.30
Consolidated Net Income
508.40
322.30
1,945.40
192.90
537.80
Net Income
-
-
1,945.40
192.90
537.80
Net Income After Extraordinaries
0.00
0.00
1,945.40
192.90
537.80
Net Income Available to Common
-
-
1,945.40
225.80
570.80
EPS (Basic)
0.00
0.00
0.00
-
-
Basic Shares Outstanding
482,039.70
506,032.90
516,830.00
547,269.90
547,269.90
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
482,039.70
506,032.90
516,830.00
547,269.90
547,269.90
EBITDA
-
-
73.10
117.20
209.30
Non-Operating Interest Income
1.20
0.60
0.60
2.40
-
Preferred Dividends
-
-
-
32.90
32.90

About Mera Pharmaceuticals

View Profile
Address
73-4460 Queen Ka'Ahumanu Highway
Kailua-Kona Hawaii 96740
United States
Employees -
Website http://www.merapharma.com
Updated 07/08/2019
Mera Pharmaceuticals, Inc. is a marine biotechnology company, which engages in the provision of photobioreactor technology and owns extensive intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. It also manufactures natural astaxanthin from haematococcus pluvialis microalgae. The company was founded in June 2002 and is headquartered in Boca Raton, Fl.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.